Abnormal respiratory chain |
Dysregulation of OXPHOS |
ROS accumulation, decrease in the mitochondrial membrane potential |
[17] |
C8-SA |
Activation of DAF-16 |
Antioxidant stress |
[16] |
FUS proteinopathies |
Interference of ATP synthase complex formation |
Inhibition of mitochondrial ATP synthesis |
[26] |
Heat shock |
Activation of HSF1, upregulation of mitochondrial chaperones |
Maintenance of mitochondrial proteostasis |
[64, 65] |
Inflammation |
Involvement of TNF-α |
ROS accumulation, overload of damaged proteins |
[24] |
Microgravity stress |
Not mentioned |
ROS accumulation, decrease in locomotion behavior |
[14] |
Mitochondrial-related genes knockout |
Disorder of mitochondrial function |
Imbalance of mitochondrial homeostasis |
[17–21] |
Nanopolystyrene |
Activation of ELT-2 signaling, Wnt signaling, and insulin signaling |
ROS accumulation, decrease in locomotion behavior |
[13] |
Nicotinamide riboside |
Activation of SIRT3 |
Antioxidant stress |
[22, 23, 58] |
PolyQ |
Direct interaction with the outer membrane of the mitochondria |
ROS accumulation, decrease in the mitochondrial membrane potential |
[11, 12] |
Statins |
Inhibition of HMG-CoA reductase in the mevalonate pathway |
Interference of mitochondrial electron carriers |
[15] |
TDP-43 proteinopathies |
Inhibition of ATP synthesis |
abnormal cristae and a loss of cristae, ROS accumulation |
[27] |